Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark C Willingham

Showing results (11-20 of 100) with videos related to

Pageof 10
Sort By:
Journal of Lipid Research|March 22, 2002
Triglyceride depletion in THP-1 cells alters cholesteryl ester physical state and cholesterol effluxAaron T Lada, Mark C Willingham, Richard W St Clair
Endocrinology|March 22, 2008
Activation of phosphatidylinositol 3-kinase signaling promotes aberrant pituitary growth in a mouse model of thyroid-stimulating hormone-secreting pituitary tumorsChangxue Lu, Mark C Willingham, Fumihiko Furuya, et al.
Endocrine-Related Cancer|June 20, 2018
Metformin and JQ1 synergistically inhibit obesity-activated thyroid cancerSunmi Park, Mark C Willingham, Jun Qi, et al.
The Journal of Biological Chemistry|August 7, 2002
p27Kip1 is essential for the antiproliferative action of 1,25-dihydroxyvitamin D3 in primary, but not immortalized, mouse embryonic fibroblastsWendy N Wade, Mark C Willingham, Constantinos Koumenis, et al.
Carcinogenesis|November 28, 2006
The pituitary tumor-transforming gene promotes angiogenesis in a mouse model of follicular thyroid cancerCaroline S Kim, Hao Ying, Mark C Willingham, et al.
Molecular Carcinogenesis|June 3, 2016
Loss of tyrosine phosphorylation at Y406 abrogates the tumor suppressor functions of the thyroid hormone receptor βJeong Won Park, Li Zhao, Mark C Willingham, et al.
American Journal of Cancer Research|April 13, 2017
Inhibition of STAT3 signaling blocks obesity-induced mammary hyperplasia in a mouse modelJeong Won Park, Li Zhao, Mark C Willingham, et al.
Human Molecular Genetics|January 2, 2014
A histone deacetylase inhibitor improves hypothyroidism caused by a TRα1 mutantDong Wook Kim, Jeong Won Park, Mark C Willingham, et al.
Endocrinology|February 6, 2010
Growth activation alone is not sufficient to cause metastatic thyroid cancer in a mouse model of follicular thyroid carcinomaChangxue Lu, Li Zhao, Hao Ying, et al.
Endocrinology|June 11, 2013
Diet-induced obesity increases tumor growth and promotes anaplastic change in thyroid cancer in a mouse modelWon Gu Kim, Jeong Won Park, Mark C Willingham, et al.
Pageof 10

Showing results (11-20 of 100) with videos related to

Sort By:
Pageof 10
Journal of Lipid Research|March 22, 2002
Triglyceride depletion in THP-1 cells alters cholesteryl ester physical state and cholesterol effluxAaron T Lada, Mark C Willingham, Richard W St Clair
Endocrinology|March 22, 2008
Activation of phosphatidylinositol 3-kinase signaling promotes aberrant pituitary growth in a mouse model of thyroid-stimulating hormone-secreting pituitary tumorsChangxue Lu, Mark C Willingham, Fumihiko Furuya, et al.
Endocrine-Related Cancer|June 20, 2018
Metformin and JQ1 synergistically inhibit obesity-activated thyroid cancerSunmi Park, Mark C Willingham, Jun Qi, et al.
The Journal of Biological Chemistry|August 7, 2002
p27Kip1 is essential for the antiproliferative action of 1,25-dihydroxyvitamin D3 in primary, but not immortalized, mouse embryonic fibroblastsWendy N Wade, Mark C Willingham, Constantinos Koumenis, et al.
Carcinogenesis|November 28, 2006
The pituitary tumor-transforming gene promotes angiogenesis in a mouse model of follicular thyroid cancerCaroline S Kim, Hao Ying, Mark C Willingham, et al.
Molecular Carcinogenesis|June 3, 2016
Loss of tyrosine phosphorylation at Y406 abrogates the tumor suppressor functions of the thyroid hormone receptor βJeong Won Park, Li Zhao, Mark C Willingham, et al.
American Journal of Cancer Research|April 13, 2017
Inhibition of STAT3 signaling blocks obesity-induced mammary hyperplasia in a mouse modelJeong Won Park, Li Zhao, Mark C Willingham, et al.
Human Molecular Genetics|January 2, 2014
A histone deacetylase inhibitor improves hypothyroidism caused by a TRα1 mutantDong Wook Kim, Jeong Won Park, Mark C Willingham, et al.
Endocrinology|February 6, 2010
Growth activation alone is not sufficient to cause metastatic thyroid cancer in a mouse model of follicular thyroid carcinomaChangxue Lu, Li Zhao, Hao Ying, et al.
Endocrinology|June 11, 2013
Diet-induced obesity increases tumor growth and promotes anaplastic change in thyroid cancer in a mouse modelWon Gu Kim, Jeong Won Park, Mark C Willingham, et al.
Pageof 10